Author

André Q. Figueiredo

LAQV RequimteORCID 0000-0002-6966-4839Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Carlos LodeiroiD· 2 shared Gianluca MoronciniiD· 2 shared Hugo Miguel SantosiD· 2 shared Inês F. DomingosiD· 2 shared Jacek R. WiśniewskiiD· 2 shared José Luís CapeloiD· 2 shared Luís B. CarvalhoiD· 2 shared Rajiv DhiriD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Carlos LodeiroORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

To Recover or Not to Recover: A Urinary Proteomic Perspective on Severe Acute Kidney Injury

André Q. Figueiredo, Inês F. Domingos, Sílvia Coelho, Maria Guadalupe Cabral, Marta Belchior Lopes, Luís B. Carvalho, Hugo López-Fernández, José Luís Capelo, Carlos Lodeiro, Rajiv Dhir, António Jacinto, Jacek R. Wiśniewski, Gianluca Moroncini, Hugo Miguel Santos

This study evaluates a urinary FABP3/APOA1 ratio as a predictor of renal recovery after severe AKI, showing high accuracy in both discovery and validation cohorts.

bioRxiv · Oct 14, 2026 · PreprintBiochemistry

Absolute quantitative proteomics guides patient-stratified drug repurposing in clear cell and papillary renal cell carcinoma.

André Q. Figueiredo, Inês F. Domingos, Carlos Lodeiro, Rajiv Dhir, Luís B. Carvalho, Laura Mercolini, Jacek R. Wiśniewski, Gianluca Moroncini, Mariana Silva Medeiros, Luís Campos Pinheiro, Hélder Mansinho, Hugo Miguel Santos, Dimitrios K. Korentzelos, José Luís Capelo

This paper uses absolute quantitative proteomics to identify patient-specific drug repurposing strategies for clear cell and papillary renal cell carcinoma.

bioRxiv · Jul 17, 2026 · PreprintBiochemistry